Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Cash Flow Reinvestment Rate
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Cash Flow Reinvestment Rate of 0.29x as of March 2023, reinvesting €54.13 Million (capex €44.48 Million plus investments €9.65 Million) from operating cash flow of €186.97 Million. Check 2TZ cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 12 annual periods. Explore Tianjin Zhong Xin Pharmaceutical Group C long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year capital reinvestment analysis for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For live market cap and broader valuation context, see 2TZ stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.05x | €1.41 Billion | €461.07 Million | €118.61 Million | ▲ +205.1% |
| 2024 | 1.00x | €925.65 Million | €924.67 Million | €117.81 Million | ▼ -2.9% |
| 2023 | 1.03x | €709.84 Million | €688.49 Million | €140.93 Million | ▲ +481.0% |
| 2022 | 0.18x | €120.18 Million | €677.25 Million | €107.90 Million | ▼ -69.2% |
| 2021 | 0.58x | €491.87 Million | €852.40 Million | €156.95 Million | ▲ +68.3% |
| 2020 | 0.34x | €230.21 Million | €671.42 Million | €189.16 Million | ▼ -44.1% |
| 2019 | 0.61x | €303.67 Million | €495.49 Million | €205.61 Million | ▼ -62.9% |
| 2018 | 1.65x | €578.87 Million | €350.14 Million | €175.81 Million | ▲ +237.4% |
| 2016 | 0.49x | €204.73 Million | €417.77 Million | €116.20 Million | ▼ -61.4% |
| 2015 | 1.27x | €457.26 Million | €360.58 Million | €92.64 Million | ▲ +116.0% |
| 2014 | 0.59x | €168.37 Million | €286.85 Million | €70.15 Million | ▼ -63.7% |
| 2013 | 1.61x | €344.69 Million | €213.44 Million | €72.42 Million | — |